Related content

Growth Inhibition and Differentiation Induced by Peroxisome Proliferator Activated Receptor Gamma Ligand Rosiglitazone in Human Melanoma Cell Line A375

By  

Medical Oncology, Vol. 23, Iss. 3, 2006-09 ,pp. : 393-402

Humana Press, Inc

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ ligand inhibits cell growth and invasion of human pancreatic cancer cells

By Hashimoto Koji   Ethridge Richard   Evers B.  

International Journal of Gastrointestinal Cancer, Vol. 32, Iss. 1, 2002-08 ,pp. : 7-22

Humana Press, Inc

Access to resources Recommend Favorite

Ligand-Activated Peroxisome Proliferator-Activated Receptor β/δ Modulates Human Endometrial Cancer Cell Survival

By Ma J.   Monsivais D.   Dyson M.   Coon J.   Malpani S.   Ono M.   Zhao H.   Xin H.   Pavone M.   Kim J.   Chakravarti D.   Bulun S.  

Hormones and Cancer, Vol. 4, Iss. 6, 2013-12 ,pp. : 358-370

Springer Publishing Company

Access to resources Recommend Favorite

Use of the Peroxisome Proliferator-Activated Receptor (PPAR)  Ligand Troglitazone as Treatment for Refractory Breast Cancer: A Phase II Study

By Burstein H.J.  

Breast Cancer Research and Treatment, Vol. 79, Iss. 3, 2003-06 ,pp. : 391-397

Springer Publishing Company

Access to resources Recommend Favorite

Peroxisome proliferator-activated receptor γ ligand troglitazone and TRAIL synergistically induce apoptosis

By            

Oncology Reports, Vol. 31, Iss. 2, 2014-01 ,pp. : 947-954

Spandidos Publications

Access to resources Recommend Favorite